PharmaResearch Products has
participated in the management of Swedish pharmaceutical company, Promore
Pharma, by investing and stake acquisition for joint development of anti-adhesion
medicine ‘PXL01’. Promore Pharma is currently promoting to list their
company in Swedish stock market. PharmaReserach products is responsible for
R&D investment and providing clinical samples and will obtain product
license for the global market in near future.